Forskning ved Københavns Universitet - Københavns Universitet

Forside

Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

  • Kim Hørslev-Petersen
  • Hetland, Merete Lund
  • Peter Junker
  • Jan Pødenphanth
  • Torkell Ellingsen
  • Palle Ahlqvist
  • Hanne M. Lindegaard
  • Asta Linauskas
  • Annette Schlemmer
  • Mette Y. Dam
  • Ib Hansen
  • Hans Chr. Horn
  • Anette Jørgensen
  • Sophine Boysen Krintel
  • Johnny Raun
  • Christian G. Ammizbøll
  • Johansen, Julia Sidenius
  • Østergaard, Mikkel
  • Kristian Stengaard-Pedersen
Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.
OriginalsprogEngelsk
TidsskriftArthritis & Rheumatism
Vol/bind63
Udgave nummer10 (suppl.)
Sider (fra-til)S147
Antal sider1
ISSN0004-3591
StatusUdgivet - 2011

ID: 40159956